- Home
- TSVT vs SABA Comparison
TSVT vs SABA Comparison
Compare TSVT & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- SABA
- Stock Information
- Founded
- TSVT 2021
- SABA 1988
- Country
- TSVT United States
- SABA United States
- Employees
- TSVT N/A
- SABA N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- TSVT Health Care
- SABA
- Exchange
- TSVT Nasdaq
- SABA Nasdaq
- Market Cap
- TSVT 160.4M
- SABA 246.4M
- IPO Year
- TSVT N/A
- SABA N/A
- Fundamental
- Price
- TSVT $3.07
- SABA $8.87
- Analyst Decision
- TSVT Buy
- SABA
- Analyst Count
- TSVT 6
- SABA 0
- Target Price
- TSVT $10.40
- SABA N/A
- AVG Volume (30 Days)
- TSVT 270.9K
- SABA 290.0K
- Earning Date
- TSVT 11-12-2024
- SABA 01-01-0001
- Dividend Yield
- TSVT N/A
- SABA 12.91%
- EPS Growth
- TSVT N/A
- SABA N/A
- EPS
- TSVT N/A
- SABA N/A
- Revenue
- TSVT $45,620,000.00
- SABA N/A
- Revenue This Year
- TSVT N/A
- SABA N/A
- Revenue Next Year
- TSVT $36.09
- SABA N/A
- P/E Ratio
- TSVT N/A
- SABA N/A
- Revenue Growth
- TSVT N/A
- SABA N/A
- 52 Week Low
- TSVT $2.78
- SABA $3.64
- 52 Week High
- TSVT $6.40
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- TSVT 32.27
- SABA 49.76
- Support Level
- TSVT $2.78
- SABA $8.73
- Resistance Level
- TSVT $4.07
- SABA $9.14
- Average True Range (ATR)
- TSVT 0.24
- SABA 0.15
- MACD
- TSVT -0.05
- SABA -0.03
- Stochastic Oscillator
- TSVT 12.02
- SABA 32.27
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.